Search - tctmd.com

Displaying 201 - 220 of 1376

Sort: Relevancy | Date

Presentation TCT 2021

Case 3: Yellow Light TMVr – Barlow’s Valve With Multiple Prolapsing Segments

Presenter: Vivian Ng

November 06, 2021

Presentation TCT 2021

AXON Therapeutics

Presenter: Sanjiv Shah

November 06, 2021

Presentation TCT 2021

Case 2: Yellow Light TMVr – Case With Borderline MVOA and Prior Failed Surgical Annuloplasty

Presenter: Marc Katz

November 06, 2021

Presentation TCT 2021

CVRx - Barostimulation -- CVRx and LivaNova

Presenter: Michael R. Zile

November 06, 2021

Presentation TCT 2021

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Presenter: Daniel Burkhoff

November 06, 2021

Presentation TCT 2021

Case 1: Green Light – TMVr Based on Echo Imaging

Presenter: Gnalini Sathananthan

November 06, 2021

Presentation TCT 2021

LV Reconstruction II: Bioventrix

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

LV Reconstruction I: Ancora

Presenter: Nadira Hamid

November 06, 2021

Presentation TCT 2021

Overview of Devices for HF: Current and Future Prospects

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

Optimal Echo Techniques for MR Assessment: TTE or TEE? 2D or 3D?

Presenter: Konstantinos Koulogiannis

November 06, 2021

Presentation TCT 2021

Is It Prime Time to Treat Vulnerable Plaque?

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

Myths and Misperceptions of Proportionate vs Disproportionate MR

Presenter: Paul Grayburn

November 06, 2021

Presentation TCT 2021

Classification and Quantification of Mitral Regurgitation

Presenter: Linda Gillam

November 06, 2021

Presentation TCT 2021

Vulnerable Plaques Detected With OCT Adds to Physiology

Presenter: Colin Berry

November 06, 2021

Presentation TCT 2021

What Plaque Characteristics Cause Future Events: Plaque Burden, Lipid, Ischemia, or Other?

Presenter: David Erlinge

November 06, 2021

Presentation TCT 2021

TCT 586: Cause If You Perfed It You Could Have Put A Ring On It: The First In Human Use Of The Ringer Perfusion Balloon Catheter For The Management Of Coronary Perforation

Presenter: Christopher Li

November 06, 2021

Presentation TCT 2021

Local Hemodynamics for Plaque Vulnerability

Presenter: Shengxian Tu

November 06, 2021

Presentation TCT 2021

Debate: It’s All About the Plaque – Atherosclerotic Burden Is the Most Important Predictor!

Presenter: Ziad Ali

November 06, 2021

Presentation TCT 2021

Debate: It’s All About the Flow – Ischemia Predicts Events!

Presenter: William Fearon

November 06, 2021

Presentation TCT 2021

Case Presentation 1 Case: Vulnerable Stenosis by CTA, but FFR Negative or Borderline (From Dr. Koo); Vulnerable Stenosis by OCT/IVUS/NIRS/s Ischemia (From Dr. Erlinge)

Presenter: Jeehoon Kang

November 06, 2021

Advertisement

Case 3: Yellow Light TMVr – Barlow’s Valve With Multiple Prolapsing Segments

AXON Therapeutics

Case 2: Yellow Light TMVr – Case With Borderline MVOA and Prior Failed Surgical Annuloplasty

CVRx - Barostimulation -- CVRx and LivaNova

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Case 1: Green Light – TMVr Based on Echo Imaging

LV Reconstruction II: Bioventrix

LV Reconstruction I: Ancora

Overview of Devices for HF: Current and Future Prospects

Optimal Echo Techniques for MR Assessment: TTE or TEE? 2D or 3D?

Is It Prime Time to Treat Vulnerable Plaque?

Myths and Misperceptions of Proportionate vs Disproportionate MR

Classification and Quantification of Mitral Regurgitation

Vulnerable Plaques Detected With OCT Adds to Physiology

What Plaque Characteristics Cause Future Events: Plaque Burden, Lipid, Ischemia, or Other?

TCT 586: Cause If You Perfed It You Could Have Put A Ring On It: The First In Human Use Of The Ringer Perfusion Balloon Catheter For The Management Of Coronary Perforation

Local Hemodynamics for Plaque Vulnerability

Debate: It’s All About the Plaque – Atherosclerotic Burden Is the Most Important Predictor!

Debate: It’s All About the Flow – Ischemia Predicts Events!

Case Presentation 1 Case: Vulnerable Stenosis by CTA, but FFR Negative or Borderline (From Dr. Koo); Vulnerable Stenosis by OCT/IVUS/NIRS/s Ischemia (From Dr. Erlinge)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content